Prevention of Syncope by Cardiac Pacing in Patients With Bifascicular Block
Prevention of Syncope by Cardiac Pacing in Patients With Bifascicular Block
Study Objective

 The purpose of this study is to evaluate the efficacy of bradycardia pacing with respect to
 patient symptoms in patients with bifascicular block and syncope of unexplained origin.
Primary endpoint

 First occurrence of a composite of Syncope of any origin OR Presyncopal episode with
 documented cardioinhibitory origin OR Atrioventricular block of any degree; all associated
 with patient symptoms

 Design:

 -  Randomized, prospective, single blinded, two parallel arms

 -  Treatment group : DDD60 - programmed in DDD mode / 60 lower limit

 -  Control Group: DDI30 - programmed in DDI mode / 30 lower limit

 -  Randomization type: block randomization: Block size: 4, allocation ratio 1:1

 Sample: 100 patients

 Population

 -  Patients with bifascicular block with at least one syncopal episode within the last 6
 months preceding enrollment.

 -  Patients should be negative to a series of pre-enrollment screening in order to exclude:

 -  Brady-tachy syndrome, vasovagal syncope or carotid sinus syndrome, atrial fibrillation,
 inducible AV block

 -  Ejection fraction >=40%

 -  Mean nocturnal heart rate >=35 bpm
Inclusion Criteria:

 -  Evidence of Bifascicular block

 -  At least one episode of syncope during last 6 months from the enrollment

 Exclusion Criteria:

 -  Patients with Brady-tachy syndrome that needs of pacemaker to prevent the symptomatic
 bradycardia o symptomatic tachycardia arrhythmia

 -  Patients with vasovagal syndrome by positive TTT or carotid sinus syndrome

 -  Patients with Chronic Atrial Fibrillation

 -  Patients with Atrial Ventricular Block induces at EPS